BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 103 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $37,210,000 | -65.7% | 990,943 | -63.9% | 1.00% | -65.0% |
| Q2 2018 | $108,429,000 | +52.2% | 2,743,647 | -6.3% | 2.84% | +42.5% |
| Q1 2018 | $71,224,000 | +911.0% | 2,927,449 | +1021.1% | 2.00% | +752.6% |
| Q4 2017 | $7,045,000 | -69.2% | 261,134 | -57.3% | 0.23% | -46.5% |
| Q3 2017 | $22,886,000 | +662.9% | 612,268 | +410.2% | 0.44% | +189.4% |
| Q2 2017 | $3,000,000 | – | 120,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |